FundedIQ
Biotechnology

Concert Bio: Funding, Investors & Team (Sep 2026)

Concert Bio helps businesses create optimal microbial communities.

www.concert.bio LinkedIn London, United Kingdom 1-10 employees
Total raised
$5.0M
Rounds
6
Latest
Undisclosed round
Jun 2026

Concert Bio has raised $5.0M across 6 funding rounds on record, the most recent an undisclosed round of $130k announced in Jun 2026.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Concert Bio Company Profile and Key Stats

Total funding raised
$5.0M
across 6 rounds on record
Funding rounds on record
6
Latest funding round
Undisclosed round
$130k in Jun 2026
Employees
1-10
reported band
Headquarters
London, United Kingdom

Latest funding round on record: Jun 2026.

Concert Bio Funding Rounds

Date
Round
Amount
Undisclosed round
$130k
Undisclosed round
$130k
Undisclosed round
$1.7M
Undisclosed round
$600k
Undisclosed round
$610k
Pre-Seed
$1.8M

Concert Bio raised $1.8M in a Pre-Seed announced in Aug 2022.

4 months later, an undisclosed round of $610k was announced in Dec 2022.

3 months later, an undisclosed round of $600k was announced in Mar 2023.

1.6 years later, an undisclosed round of $1.7M was announced in Oct 2024.

1.4 years later, an undisclosed round of $130k was announced in Mar 2026.

3 months later, an undisclosed round of $130k was announced in Jun 2026.

Concert Bio Founders and Leadership Team

Name
Role
Contact
Paul Rutten
Founder
Locked

Contact details for the Concert Bio team: 1 of 1 has an email address on file.

Start 14-day free trial →

Concert Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
5,273
$4.0M

Concert Bio's latest round of $130k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Concert Bio in Biotechnology and London

Companies Similar to Concert Bio

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…

Undisclosed round $3.6M

Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…

Undisclosed round $3.0M

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Series A $32.5M

IMU is a discovery engine mapping the immune system to advance precision medicine.

Series A $38.4M

Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…

Undisclosed round $5.4M

Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…

Undisclosed round

Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…

Pre-Seed $740k

Five is a biometric payment services company that offers thumb recognition technology for safe transactions.

Seed $6.0M

Scarlet Therapeutics is developing the novel red blood cell-based therapeutics (tRBCs) generation platform.

Seed $4.4M

Concert Bio Funding FAQs

What does Concert Bio do?

Concert Bio helps businesses create optimal microbial communities.

How much funding has Concert Bio raised?

Concert Bio has raised $5.0M across 6 rounds on record. The most recent is an undisclosed round of $130k announced in Jun 2026.

When did Concert Bio last raise funding?

Concert Bio's most recent funding round on record is an undisclosed round of $130k, announced in Jun 2026.

Who founded Concert Bio?

FundedIQ lists Paul Rutten (Founder) at Concert Bio.

Where is Concert Bio headquartered?

Concert Bio is based in London, England, United Kingdom.

How many employees does Concert Bio have?

Concert Bio is in the 1-10 employee band.

How does Concert Bio's funding compare to other Biotechnology startups?

Concert Bio's latest round of $130k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Concert Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Concert Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.